Table 3.
Postoperative clinical course in patients with hepatocellular carcinoma with and without renal dysfunction (RD)
| Variable | RD group (n = 17) | Non-RD group (n = 705) | P-value |
|---|---|---|---|
| Hospital stay, days, mean ± SD | 41.0 ± 8.1 | 28.4 ± 1.2 | 0.026 |
| Complications, n (%) | 11 (64.7) | 319 (45.2) | 0.268 |
| SSI, n (%) | 3 (17.6) | 80 (11.3) | 0.450 |
| Massive ascites, n (%) | 6 (35.3) | 101 (14.3) | 0.034 |
| Pleural effusion, n (%) | 9 (52.9) | 124 (17.6) | 0.001 |
| Postoperative bleeding, n (%) | 0 | 14 (2.0) | 0.412 |
| Bile leakage, n (%) | 1 (5.8) | 36 (5.1) | 0.888 |
| Gastrointestinal bleeding, n (%) | 0 | 17 (2.4) | 0.365 |
| Liver failure, n (%) | 2 (11.8) | 23 (3.3) | 0.131 |
SD, standard deviation; SSI, surgical site infection.